학술논문
The Phase II MutHER Study of Neratinib Alone and in Combination with Fulvestrant in HER2-Mutated, Non-amplified Metastatic Breast Cancer
Document Type
Article
Author
Ma, C.X.; Thomas, S.; Anderson, J.; Haas, B.; Bose, R.; Luo, J.; Gao, F.; Freedman, R.A.; Lin, N.U.; Winer, E.P.; Pluard, T.J.; Nangia, J.R.; Lu, J.; Valdez-Albini, F.; Cobleigh, M.; Jones, J.M.; Kelly Marcom, P.; Kimmick, G.; Bucheit, L.; Bryce, R.; Lalani, A.S.; Carey, L.A.; Goetz, M.P.; Pegram, M.D.; Ellis, M.J.
Source
In: Clinical Cancer Research . (Clinical Cancer Research, 1 April 2022, 28(7):1258-1267)
Subject
Language
English
ISSN
15573265
10780432
10780432